Portage Biotech Analyst Ratings
Portage Biotech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/07/2023 | 297.08% | Cantor Fitzgerald | → $11 | Reiterates | Overweight → Overweight |
| 08/31/2023 | 297.08% | Cantor Fitzgerald | → $11 | Reiterates | Overweight → Overweight |
| 08/02/2023 | 224.89% | HC Wainwright & Co. | $21 → $9 | Maintains | Buy |
| 08/01/2023 | 297.08% | Cantor Fitzgerald | $16 → $11 | Maintains | Overweight |
| 12/01/2022 | 658.07% | HC Wainwright & Co. | $22 → $21 | Maintains | Buy |
| 11/30/2022 | 549.77% | Oppenheimer | $26 → $18 | Maintains | Outperform |
| 09/20/2022 | 694.17% | HC Wainwright & Co. | $32 → $22 | Maintains | Buy |
| 03/07/2022 | 1055.15% | HC Wainwright & Co. | → $32 | Initiates Coverage On | → Buy |
| 09/21/2021 | 982.95% | Oppenheimer | → $30 | Initiates Coverage On | → Outperform |
| 09/02/2021 | 1343.94% | B. Riley Securities | → $40 | Initiates Coverage On | → Buy |
| 08/19/2021 | 1163.45% | Cantor Fitzgerald | → $35 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/07/2023 | 297.08% | 康托·菲茨杰拉德 | →$11 | 重申 | 超重→超重 |
| 2023年08月31日 | 297.08% | 康托·菲茨杰拉德 | →$11 | 重申 | 超重→超重 |
| 08/02/2023 | 224.89% | HC Wainwright公司 | $21→$9 | 维护 | 买 |
| 08/01/2023 | 297.08% | 康托·菲茨杰拉德 | $16→$11 | 维护 | 超重 |
| 12/01/2022 | 658.07% | HC Wainwright公司 | $22→$21 | 维护 | 买 |
| 2022年11月30日 | 549.77% | 奥本海默 | $26→$18 | 维护 | 跑赢大盘 |
| 09/20/2022 | 694.17% | HC Wainwright公司 | $32→$22 | 维护 | 买 |
| 03/07/2022 | 1055.15% | HC Wainwright公司 | →$32 | 开始承保 | →购买 |
| 2021/09/21 | 982.95% | 奥本海默 | →$30 | 开始承保 | →跑赢大盘 |
| 09/02/2021 | 1343.94% | B.莱利证券 | →$40 | 开始承保 | →购买 |
| 2021/08/19 | 1163.45% | 康托·菲茨杰拉德 | →$35 | 开始承保 | →超重 |
What is the target price for Portage Biotech (PRTG)?
Porage Biotech(PRTG)的目标价是多少？
The latest price target for Portage Biotech (NASDAQ: PRTG) was reported by Cantor Fitzgerald on September 7, 2023. The analyst firm set a price target for $11.00 expecting PRTG to rise to within 12 months (a possible 297.08% upside). 7 analyst firms have reported ratings in the last year.
康托·菲茨杰拉德于2023年9月7日报道了Porage Biotech(纳斯达克：PRTG)的最新目标价。这家分析公司将目标价定为11美元，预计PRTG将在12个月内上涨(可能上涨297.08%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Portage Biotech (PRTG)?
波蒂奇生物技术公司(PRTG)的最新分析师评级是多少？
The latest analyst rating for Portage Biotech (NASDAQ: PRTG) was provided by Cantor Fitzgerald, and Portage Biotech reiterated their overweight rating.
波蒂奇生物技术公司(纳斯达克代码：PRTG)的最新分析师评级由康托·菲茨杰拉德提供，波蒂奇生物技术公司重申其增持评级。
When is the next analyst rating going to be posted or updated for Portage Biotech (PRTG)?
Porage Biotech(PRTG)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Portage Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Portage Biotech was filed on September 7, 2023 so you should expect the next rating to be made available sometime around September 7, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与波蒂奇生物技术公司的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Porage Biotech的上一次评级是在2023年9月7日提交的，所以你应该预计下一次评级将在2024年9月7日左右的某个时候公布。
Is the Analyst Rating Portage Biotech (PRTG) correct?
分析师对Porage Biotech(PRTG)的评级正确吗？
While ratings are subjective and will change, the latest Portage Biotech (PRTG) rating was a reiterated with a price target of $0.00 to $11.00. The current price Portage Biotech (PRTG) is trading at is $2.77, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Porage Biotech(PRTG)评级被重申，目标价在0.00美元至11.00美元之间。Porage Biotech(PRTG)目前的交易价格为2.77美元，在分析师的预测范围内。